Balansag, Rodelia B.

HRN: 08-69-08  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/11/2024
07/24/2024
IVT
2.25 G
Q8h
Infected Wound
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: